Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled bronchodilator or inhaled furosemide to improve exercise breathing in pulmonary arterial hypertension
RBR-66359jNot yet recruiting
- Sponsor
- Universidade Federal do Rio Grande do Sul
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of fenoterol + ipratropium and furosemide in pulmonary arterial hypertension (PAH), sponsored by Universidade Federal do Rio Grande do Sul. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
fenoterol + ipratropiumfurosemide
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on RBR-66359j.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-66359j.